Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin and heart failure–related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials
Phiwayinkosi V. Dludla, Tawanda M. Nyambuya, Rabia Johnson, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 6, pp. 1437-1445
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress
Phiwayinkosi V. Dludla, Sihle E. Mabhida, Khanyisani Ziqubu, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 3, pp. 130-146
Open Access | Times Cited: 108
Human trials exploring anti-aging medicines
Leonard Guarente, David Sinclair, Guido Kroemer
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 354-376
Open Access | Times Cited: 70
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1834-1834
Open Access | Times Cited: 74
Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK‐dependent mechanisms
Yizhi Bu, Mei Peng, Xinyi Tang, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 19, pp. 4886-4903
Open Access | Times Cited: 50
Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?
Marta Wołosowicz, Sławomir Prokopiuk, Tomasz W. Kamiński
Medicina (2022) Vol. 58, Iss. 4, pp. 472-472
Open Access | Times Cited: 39
Okra ameliorates hyperglycaemia in pre-diabetic and type 2 diabetic patients: A systematic review and meta-analysis of the clinical evidence
Kabelo Mokgalaboni, Sogolo Lucky Lebelo, Perpetua Modjadji, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
Qutuba G. Karwi, Kim L. Ho, Simran Pherwani, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 3, pp. 686-715
Open Access | Times Cited: 55
Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response
Namrita Kaur, Yingshu Guan, Rida Raja, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 48
NETosis as a Pathogenic Factor for Heart Failure
Shuang Ling, Jin‐Wen Xu
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, pp. 1-24
Open Access | Times Cited: 42
Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases
Tian Li, Rui Providência, Wenhua Jiang, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 311-322
Closed Access | Times Cited: 29
Adipokines as a therapeutic target by metformin to improve metabolic function: A systematic review of randomized controlled trials
Phiwayinkosi V. Dludla, Bongani B. Nkambule, Sithandiwe E. Mazibuko-Mbeje, et al.
Pharmacological Research (2020) Vol. 163, pp. 105219-105219
Closed Access | Times Cited: 48
Ketone therapy for heart failure: current evidence for clinical use
Shingo Takahara, Shubham Soni, Zaid H. Maayah, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 4, pp. 977-987
Closed Access | Times Cited: 40
Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
Jan Beneš, Martin Kotrč, Katerina Kroupova, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Implications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity
Panagiotis Efentakis, Aimilia Varela, Sofia Lamprou, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 16, pp. 2964-2990
Open Access | Times Cited: 4
The role of NETosis in heart failure
Sawa Kostin, Florian Krizanic, Theodoros Kelesidis, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 5, pp. 1097-1106
Closed Access | Times Cited: 4
Physical Exercise Potentially Targets Epicardial Adipose Tissue to Reduce Cardiovascular Disease Risk in Patients with Metabolic Diseases: Oxidative Stress and Inflammation Emerge as Major Therapeutic Targets
Thembeka A. Nyawo, Carmen Pheiffer, Sithandiwe E. Mazibuko-Mbeje, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 24
Comparison of the effects of metformin and empagliflozin on cardiac function in heart failure with preserved ejection fraction mice
Xiehong Liu, Huiqi Zhao, Sisi Liu, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
The Hormetic Effect of Metformin: “Less Is More”?
Isabella Panfoli, Alessandra Puddu, Nadia Bertola, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6297-6297
Open Access | Times Cited: 22
Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials
Ahmed Kamel, Nirmeen A. Sabry, Samar Farid
BMC Cardiovascular Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Impact of DPP-4 Inhibitors in Patients with Diabetes Mellitus and Heart Failure: An In-Depth Review
Francisco Epelde
Medicina (2024) Vol. 60, Iss. 12, pp. 1986-1986
Open Access | Times Cited: 2
Energy metabolism homeostasis in cardiovascular diseases.
Lu-Yun Wang, Chen Chen
PubMed (2021) Vol. 18, Iss. 12, pp. 1044-1057
Closed Access | Times Cited: 12
Vitamin K: A vital micronutrient with the cardioprotective potential against diabetes-associated complications
Kabelo Mokgalaboni, Bongani B. Nkambule, Yonela Ntamo, et al.
Life Sciences (2021) Vol. 286, pp. 120068-120068
Closed Access | Times Cited: 11
Insulin secretory actions of ethanolic extract of Acacia arabica bark in high fat-fed diet-induced obese Type 2 diabetic rats
Prawej Ansari, Sara S. Islam, Samia Akther, et al.
Bioscience Reports (2023) Vol. 43, Iss. 5
Open Access | Times Cited: 4
Policaptil Gel Retard in adult subjects with the metabolic syndrome: Efficacy, safety, and tolerability compared to metformin
Giuseppina Guarino, Teresa Della Corte, Felice Strollo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 3, pp. 901-907
Open Access | Times Cited: 10
Unraveling aging from transcriptomics
Yuanfang Huang, Sheng Zhu, Shuai Yao, et al.
Trends in Genetics (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top